Description
PERFORM LABORATORY TEST
First action · last action
2009-09-21 · 2010-01-22
Transactions
2
First transaction's obligation
$80,000
Base + all options value (sum of deltas)
$65,176
Extent competed
NOT COMPETED
Other than full & open authority
AUTHORIZED BY STATUTE
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621511 · MEDICAL LABORATORIES
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-09-21+$80,000= $80,000
- Mod 12010-01-22-$14,824= $65,176
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-09-21 | +$80,000 | $80,000 | PERFORM LABORATORY TEST |
| Mod 1· CLOSE OUT | 2010-01-22 | −$14,824 | $65,176 | PERFORM LABORATORY TEST |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI X2XMAQLR9DA8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79724A0018 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C26124N0260 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $11,882 | FY2024 |
| 36C26023F0186 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $144,553 | FY2023 |
| 36C26223F0045 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $246,001 | FY2023 |
| 36C26223F0022 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $266,652 | FY2023 |
| 36C26222F0606 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $20,049 | FY2022 |
Other recipients under Q301 from 243-NETWORK CONTRACTING OFFICE 03 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24316P1654 | VERACYTE, INC. | 243-NETWORK CONTRACTING OFFICE 03 | $11,749 | FY2016 |
| VA24316P1048 | DATA INNOVATIONS LLC | 243-NETWORK CONTRACTING OFFICE 03 | $12,500 | FY2016 |
| VA24315C0137 | TRIANGLE MANIFOLD SERVICES, INC. | 243-NETWORK CONTRACTING OFFICE 03 | $11,700 | FY2015 |
| VA24315P2997 | VERACYTE, INC. | 243-NETWORK CONTRACTING OFFICE 03 | $0 | FY2015 |
| VA24315J2661 | ROCHE DIAGNOSTICS CORPORATION | 243-NETWORK CONTRACTING OFFICE 03 | $105,071 | FY2015 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA632C90452_3600_-NONE-_-NONE- · retrieved 2026-09-26.